PRMT5 and retinoblastoma: Mechanistically, silencing of PRMT5 reduces H3K4me3-mediated vascular endothelial growth factor A (VEGFA) transcription and further suppresses the expression of MMP1, MMP2, and MMP9 to inhibit the proliferation of RB.